China rejected on July 22 a World Health Organization (WHO) plan for a second phase of an investigation into the origin of the coronavirus, which includes the hypothesis it could have escaped from a Chinese laboratory, a top health official said.
Two doses of Pfizer, AstraZeneca shots effective against Delta variant: study
AstraZeneca, BNT162b2 (Pfizer and BioNTech), Business, Clinical Studies, COVID-19 Doses, COVID-19 Vaccines, Covid-19 Variants, Delta Variant (B.1.617.2; India), Health Officials, New England Journal of Medicine, Public Health England (PHE), R&DTwo doses of Pfizer or AstraZeneca’s Covid-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study published on July 21 showed.
U.S. President Joe Biden said the Centers for Disease Control is likely to advise that kids who have not been vaccinated against Covid-19 should wear masks when they return from summer holidays to school in the fall.
As part of a nationwide response to the threat posed by the more contagious Delta coronavirus variant, New York City will require Covid-19 vaccinations or weekly tests for workers at city-run hospitals and clinics.
Delta variant behind more than 80% of U.S. cases, Fauci says
China, COVID-19 cases, Covid-19 Variants, Delta Variant (B.1.617.2; India), Dr. Anthony Fauci (Director), Government, India, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Senate, United States, WuhanThe Delta variant of the coronavirus is the cause of more than 80 percent of new U.S. Covid-19 cases, but the authorized vaccines remain more than 90 percent effective in preventing hospitalizations and deaths, said top U.S. infectious disease expert Anthony Fauci during a U.S. Senate hearing on July 20.
Life expectancy in the United States fell by a year and a half in 2020 to 77.3 years – the lowest level since 2003 – primarily due to the deaths caused by the Covid-19 pandemic, a U.S. health agency said on July 21.
Sinopharm’s Covid-19 vaccine elicited weaker antibody responses against the Delta variant, based on the first published study of its effect against the more contagious version.
Scientists are working on a benchmark for Covid-19 vaccine efficacy that would allow drugmakers to conduct smaller, speedier human trials to get them to market and address a huge global vaccine shortage.
Rising coronavirus cases fuel resurgence fears as Biden ramps up vaccination push
Clinical Trials, Coronavirus, Coronavirus Disease (COVID-19) Pandemic, COVID-19 cases, COVID-19 Deaths, COVID-19 inoculations, COVID-19 vaccination rates, COVID-19 Vaccines, Covid-19 Variants, Delta Variant (B.1.617.2; India), Hospitalized COVID-19 Patients, Joe Biden, Outbreaks, R&D, Reuters Data, Stock Markets, United StatesSwiftly rising coronavirus cases across the United States and abroad fueled fears of a pandemic resurgence on July 19 and sent shockwaves through stock markets as the highly contagious Delta variant appeared to be taking hold.
In a roundup of scientific studies on the novel coronavirus, a small study suggests no traces of mRNA vaccines end up in mothers’ breast milk and a gene called IFI27 that becomes activated early in Covid-19 might help identify people most likely to have contracted the virus after coming in contact with an infected person.